Synopsys (SNPS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Synopsys has taken a beating this year while its fundamentals moved sharply in the opposite direction, and that gap between price and earnings power is exactly where our model tends to find its best setups.
Synopsys powers nearly every advanced chip on the planet, yet its stock has cratered while the broader market surged, and Wall Street analysts are betting that gap closes in a hurry.
Marvell and Synopsys both profit from the AI chip boom, but one company is quietly handing hyperscalers the tools to cut the other out entirely. The tension between them reveals something uncomfortable about where custom silicon money actually flows.
The mean of analysts' price targets for Synopsys (SNPS) points to a 25.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Synopsys just posted explosive revenue growth that dwarfs its closest EDA rival, yet the market prices it at a fraction of that rival's multiple. Something in that gap tells a story most investors are missing.
PDF Solutions outpaces Synopsys with stronger revenue growth, improving margins, major customer wins and a 20% growth target.
Synopsys raises its 2026 outlook as EDA demand accelerates, Design IP rebounds and Ansys integration opens growth opportunities for fiscal 2027.
Synopsys beats Q3 estimates as EDA and Ansys fuel strong growth, while higher margins and an upgraded fiscal 2026 outlook add momentum.
Synopsys remains a Buy despite a 14% stock decline and recent underperformance versus the benchmark. SNPS delivered its fourth consecutive double-beat quarter and upwardly revised FY guidance, reinforcing confidence in management execution. At a 24x 15-month forward P/E, SNPS trades at only a modest 3% premium to peers, justified by consistent top- and bottom-line growth.
Synopsys, Inc. (SNPS) Q3 2026 Earnings Call Transcript